Stocks
eHealth Financial Statements (EHTH) |
||||||||||
| eHealthsmart-lab.ru | % | 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 01.03.2022 | 31.12.2022 | 01.03.2023 | 31.12.2023 | 29.02.2024 | 29.02.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 538.2 | 405.4 | 405.4 | 452.9 | 452.9 | 626.8 | |||
| Operating Income, bln rub | -74.4 | -102.7 | -83.1 | -29.1 | -29.1 | 53.2 | ||||
| EBITDA, bln rub | ? | -4.33 | -97.9 | -42.4 | -9.16 | -9.16 | 67.9 | |||
| Net profit, bln rub | ? | -104.4 | -119.4 | -88.7 | -28.2 | -28.2 | 33.6 | |||
| OCF, bln rub | ? | -162.6 | -26.9 | -26.9 | -6.69 | -6.69 | -100.9 | |||
| CAPEX, bln rub | ? | 20.9 | 15.5 | 15.5 | 10.8 | 10.8 | 10.5 | |||
| FCF, bln rub | ? | -183.5 | -42.4 | -42.4 | -17.5 | -17.5 | -111.4 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 3.53 | 3.53 | 6.19 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 18.4% | ||||
| OPEX, bln rub | 610.6 | 506.4 | 486.8 | 460.3 | 460.3 | 561.4 | ||||
| Cost of production, bln rub | 1.99 | 1.65 | 1.65 | 21.7 | 21.7 | 12.2 | ||||
| R&D, bln rub | 83.8 | 78.8 | 78.8 | 61.0 | 61.0 | 62.6 | ||||
| Interest expenses, bln rub | 0.845 | 0.000 | 42.9 | 11.0 | 11.0 | 5.70 | ||||
| Assets, bln rub | 1 149 | 1 113 | 1 113 | 1 113 | 1 316 | 1 316 | ||||
| Net Assets, bln rub | ? | 982.1 | 651.0 | 914.2 | 904.1 | 904.1 | 904.1 | |||
| Debt, bln rub | 41.4 | 106.8 | 106.8 | 103.2 | 103.2 | 103.2 | ||||
| Cash, bln rub | 123.2 | 144.4 | 144.4 | 121.7 | 121.7 | 121.7 | ||||
| Net debt, bln rub | -81.9 | -37.6 | -37.6 | -18.5 | -18.5 | -18.5 | ||||
| Ordinary share price, rub | 25.5 | 4.84 | 4.84 | 8.72 | 8.72 | 8.82 | ||||
| Number of ordinary shares, mln | 26.8 | 26.8 | 27.4 | 28.0 | 28.0 | 28.5 | ||||
| Market cap, bln rub | 683 | 130 | 132 | 244 | 244 | 251 | ||||
| EV, bln rub | ? | 601 | 92 | 95 | 226 | 226 | 233 | |||
| Book value, bln rub | 980 | 651 | 883 | 904 | 272 | 272 | ||||
| EPS, rub | ? | -3.90 | -4.46 | -3.24 | -1.01 | -1.01 | 1.18 | |||
| FCF/share, rub | -6.85 | -1.58 | -1.55 | -0.62 | -0.62 | -3.91 | ||||
| BV/share, rub | 36.6 | 24.3 | 32.3 | 32.3 | 9.72 | 9.56 | ||||
| EBITDA margin, % | ? | -0.81% | -24.2% | -10.5% | -2.02% | -2.02% | 10.8% | |||
| Net margin, % | ? | -19.4% | -29.5% | -21.9% | -6.23% | -6.23% | 5.37% | |||
| FCF yield, % | ? | -26.9% | -32.7% | -32.0% | -7.15% | -7.15% | -44.4% | |||
| ROE, % | ? | -10.6% | -18.3% | -9.70% | -3.12% | -3.12% | 3.72% | |||
| ROA, % | ? | -9.08% | -10.7% | -7.97% | -2.53% | -2.14% | 2.56% | |||
| P/E | ? | -6.54 | -1.09 | -1.49 | -8.66 | -8.66 | 7.47 | |||
| P/FCF | -3.72 | -3.06 | -3.12 | -14.0 | -14.0 | -2.25 | ||||
| P/S | ? | 1.27 | 0.32 | 0.33 | 0.54 | 0.54 | 0.40 | |||
| P/BV | ? | 0.70 | 0.20 | 0.15 | 0.27 | 0.90 | 0.92 | |||
| EV/EBITDA | ? | -138.7 | -0.94 | -2.24 | -24.7 | -24.7 | 3.43 | |||
| Debt/EBITDA | 18.9 | 0.38 | 0.89 | 2.02 | 2.02 | -0.27 | ||||
| R&D/CAPEX, % | 401.8% | 508.2% | 508.2% | 566.2% | 566.2% | 594.3% | ||||
| CAPEX/Revenue, % | 3.88% | 3.83% | 3.83% | 2.38% | 2.38% | 1.68% | ||||
| eHealth shareholders | ||||||||||
